期刊文献+

液质联用检测大鼠血、尿液和胆汁中氯沙坦的含量

Determination of losartan concentrations in rat plasma,urine and bile by liquid chromatography-tandem mass spectrometry
下载PDF
导出
摘要 目的:建立LC/MS/MS法测定大鼠血?尿液和胆汁中氯沙坦的浓度,研究氯沙坦在大鼠体内的药物动力学特点。方法:大鼠血浆样品采用沉淀蛋白作为前处理方法,尿液和胆汁采用液-液萃取方法进行前处理,进样检测。色谱柱为Agela Venusil MP-C182.1mm×50mm,粒径5μm;流动相A为0.1%甲酸,流动相B为0.1%甲酸(溶剂为乙腈)。采用梯度洗脱:流动相B在1.5min内从20%到95%,流速0.35ml/min,进样量为10μl,质谱仪检测,离子源为ESI源。结果:氯沙坦在血、尿液和胆汁中的线性范围为1~1000μg/L,线性良好(r>0.99),平均相对回收率>80.0%,日内和日间精密度均小于15%。结论:该检测方法操作方便,结果准确,专属性强,可用于血、尿液和胆汁中氯沙坦药物含量的测定。 Objective: To establish a liquid chromatography-tandem mass spectrometry (LC/MS/MS) method for determination of the losartan concentrations in rat plasma, urine and bile. Methods: The method was based on a protein precipitation procedure for rat plasma and liquid-liquid extraction for rat urine and bile,then the diluted extract was analyzed by LC/MS/MS using turbo ion spray (TIS) positive ion mode. Chromatography was performed on an Agela Venusil MP-C18 column (5 um particle,2.1 mm ×50 mm) by gradient elution. Mobile phase A was 0.1% formic acid in water and mobile phase B was 0.1 % formic acid in aeetonitrile. The mobile phase B increased from 20 % to 95 % within 1.5 min,with the flow rate being 0.35 ml/min and the feeding rate being 10 ul. Electrospray ionization (ESI) ion source was used. Results: The linear range of losartan was 1-1 000 ug/L in the plasma,urine and bile of rats (r〉0.99). The mean relative recovery rate was higher than 80.0% ;RSD values of intra-day and inter-day were both less than 15 %. Conclusion: The present method is easy to perform, accurate, and specific; it can be used for determination of losartan concentration in rat plasma,urine and bile.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2008年第9期1091-1095,共5页 Academic Journal of Second Military Medical University
关键词 氯沙坦 血浆 胆汁 尿 液质联用 losartan plasma bile urine LC/MS/MS
  • 相关文献

参考文献16

  • 1Ritter M A,Furtek C I,Lo M W. An improved method for the simultaneous determination of losartan and its major metabolite,EXP3174,in human plasma and urine by high-performance liquid chromatography with fluorescence detection[J]. J Pharm Biomed Anal,1997 ,15 :1021- 1029.
  • 2刘新民,戴学伟.新型血管紧张素Ⅱ受体拮抗剂-洛沙坦临床应用及安全耐受性[J].中国新医药,2003,2(2):57-58. 被引量:1
  • 3Diez J. Review of the molecular pharmacology of losartan and its possible relevance to stroke prevention in patients with hypertension[J]. Clin Ther, 2006,28 : 832-848.
  • 4Moen M D,Wagstaff A J. Losartan:a review of its use in stroke risk reduction in patients with hypertension and left ventricular hypertrophy[J].Drugs,2005,65 : 2657- 2674.
  • 5Soldner A, Spahn-Langguth H, Mutschler E. HPI.C assays to simultaneously determine the angiotensin ATI antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats[J]. J Pharm Biomed Anal,1998,16:863-873.
  • 6Farthing D,Sica D,Fakhry I,Pedro A,Gehr T W. Simple high- performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate[J]. J Chromatogr B Biomed Sci Appl, 1997,704:374- 378.
  • 7Zarghi A, Foroutan S M, Shafaati A, Khoddam A. A rapid HPLC method for the determination of losartan in human plasma using a monolithic column [J]. Arzneimittelforschung, 2005,55:569-572.
  • 8Yeung P K,Jamieson A, Smith G J, Fice D, Pollak P T. Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection[J]. Int J Pharm, 2000,204 : 17-22.
  • 9Lastra O C, I.emus I G, Sdnchez H J, Perez R F. Development and validation of an UV derivative spectrophotometrie determination of losartan potassium in tablets[J]. J Pharm Biomed Anal, 2003,33 : 175-180.
  • 10Ritter M A,Furtek C J,Lo M W. An improved method for the simultaneous determination of losartan and its major metaholite,EXP3174 ,in human plasma and urine by high-performance liquid chromatography with fluorescence detection[J]. J Pharm Biomed Anal, 1997,15 : 1021-1029.

二级参考文献21

  • 1Tang L, Kebarle P. Dependence of ion intensity in electrospray mass spectrometry on the concentration of the analytes in the electrosprayed solution. Anal Chem, 1993,65 (24) :3654.
  • 2Matuszewski BK, Conctanzer ML, Chavez - Eng CM. Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogra per milliliter concentrations. Anal Chem, 1998,70 ( 5 ) : 882.
  • 3Choi BK, Hercules DM, Gusev AI. Effect of liquid chromatography separation of complex matrices on liquid chromatography - tandem mass spectrometry signal suppression. J Chromatogr A, 2001,907 ( 1-2) :337.
  • 4Muller C,Schafer P,Stortzel M,et al. Ion suppression effects in liquid chromatography - electrospray - ionization transport - region collision induced dissociation mass spectrometry with different serum extraction methods for systematic toxicological analysis with mass spectra libraries. J Chromatogr B,2002,773:47.
  • 5Ohlenbusch G, Zwiener C, Meckenstock RU, et al. Identification and quantification of polar naphthalene derivatives in contaminated groundwater of a former gas plant site by liquid chromatography -electrospray ionization tandem mass spectrometry. J Chromalogr A,2002,967:201.
  • 6Heinig K, Bucheli F. Application of column - switching liquid chromatography - tandem mass spectrometry for the determination of pharmaceutical compounds in tissue samples. J Chromatogr 8,2002,769:9.
  • 7Weng N,Bu H,Chen Y,et al. Simultaneous development of six LC - MS - MS methods for the determination of multiple analytes in human plasma. J Pharm Biomed Anal,2002,28 : 1115.
  • 8Matuszewski BK, Conctanzer ML, Chavez -Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC - MS/MS. Anal Chem,2003,75 ( 13 ) :3019.
  • 9Miao X, Metcalfe CD. Determination of carbamazepine and its metabolites in aqueous samples using liquid chromatography - electrospray tandem mass spectrometry. Anal Chem, 2003,75 ( 15 ) : 3731.
  • 10Wu Y,Farrell Jr, Lynn K,et al. The importance of chromatographic separation in LC/MS/MS quantitatlon of drugs in biological fluids: detection, characterization, and synthesis of a previously unknown low-level nitrone metabolite of a substance P antagonist. Anal Chem. ,2003,75(3) :426.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部